ClinicalTrials.Veeva

Menu

Pneumococcal Vaccination of Otitis-prone Children

L

Lund University Hospital

Status

Completed

Conditions

Recurrent Acute Otitis Media

Treatments

Biological: Prevenar

Study type

Interventional

Funder types

Other

Identifiers

NCT01263210
LU62601

Details and patient eligibility

About

Acute otitis media (AOM) is a common childhood disease, which becomes recurrent in 15-20% of the cases. Streptococcus pneumoniae is one of the leading causative agents, and a small reduction in the number of AOM episodes has been noted in unselected child cohorts after vaccination with conjugate heptavalent pneumococcal vaccine. This study was performed in order to investigate whether vaccination could reduce the number of AOM episodes in very young, otitis-prone children.

Full description

Ninetysix children (46 vaccinated, 50 not) with an onset of AOM before six months of age, implying a high risk for developing rAOM, were recruited between 2003 and 2007. They were closely followed with clinical visits and nasopharyngeal cultures until the age of two years.

Enrollment

109 patients

Sex

All

Ages

Under 6 months old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: First episode of acute otitis media before 6 months of age and verified by an otorhinolaryngologist.

Exclusion Criteria: Allergy to the vaccine, anatomical abnormality (eg cleft palate), chromosomal abnormality, immune deficiency, prematurity, prior administration of gammaglobulin or pneumococcal vaccine and a history of idiopathic thrombocytopenic purpura.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

109 participants in 2 patient groups

Pneumococcal vaccine
Active Comparator group
Description:
Half of the children were randomized to receive heptavalent pneumococcal conjugate vaccine (before this vaccine was included in the national immunization programme).
Treatment:
Biological: Prevenar
Control
No Intervention group
Description:
Half of the children were randomized to no vaccination and functioned as controls.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems